Dr. Nancy Dreyer brings more than 30 years of epidemiologic research experience to her role as Senior Vice President and Global Chief of Scientific Affairs at IQVIA, (formerly QuintilesIMS) where she conducts research on the safety, effectiveness, and value of medical treatments. She also leads programs on sports injury analytics for two professional sports leagues in the United States. She is widely known for her work as senior editor of “Registries for Evaluating Patient Outcomes: A User’s Guide,” published by the US Agency for Research on Healthcare and Quality, now in its third edition and available in Chinese and Korean. Other notable work on quality includes her leadership of the GRACE Initiative for Good Research Practices for Observational Studies of Comparative Effectiveness, which has endorsements from the European Medicines Agency and the national payer for the UK, among others (www.graceprinciples.org).
She advises the FDA through her participation on the US National Evaluation System for Health Technology Planning Board and has worked closely with the European Medicines Agency in evaluating new uses for registries and newer methods for pharmacovigilance. She is a Fellow of the International Society of Pharmacoepidemiology and former director of that society as well as the Drug Information Association. She maintains an academic affiliation as an Adjunct Professor of Epidemiology at the UNC Gillings School of Global Public Health in Chapel Hill, and is a member of the Editorial Board of the Chinese Journal of Pharmacoepidemiology as well as an Advisor to the Center of Postmarketing Safety Evaluation at Peking University Health Science Center in China.